Responding With Evidence and Access for Childhood Headaches
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT05889624
- Status
- Recruiting
Conditions
- Chronic Migraine
- Headache
- Headache Disorders
- Headache, Migraine
- Migraine
- Migraine Disorders
- Migraine With Aura
- Migraine Without Aura
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- CBT — BEHAVIORALDuring an 8-week active treatment, participants will receive 6 telehealth CBT sessions, followed by a maintenance phase (16 weeks) when participants will receive 3 "booster" CBT sessions. The sessions will be conducted by teletherapists from the Clinical Coordinating Center at Cincinnati Children's using a standardized treatment manual. A parent/legal guardian will be included in 2 sessions teaching ways to be active coaches, encouraging use of effective coping skills and refraining from reinforcement of maladaptive coping. Each session will be about 45 minutes.
- Amitriptyline — DRUGDuring an 8-week active treatment, participants will begin taking a daily pill (amitriptyline) prescribed and managed clinically by the site headache provider. Amitriptyline will be taken once a day before bedtime. The weight based dosage will gradually be increased based on tolerability and a standardized titration protocol during the 8 week active treatment. The participant will remain on a maximum tolerated dose for the final 16 weeks (maintenance).
Study Details
This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.
Key Dates
- Start date
- Aug 22, 2023
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline)This intervention consists of Cognitive Behavioral (CBT), a mind and body based intervention using education on gate control theory of pain, behavioral strategies such as muscle relaxation, activity pacing, and cognitive strategies including distraction, problem solving, and using calming self-statements. This arm will also take a daily oral dose of Amitriptyline, which will be clinically prescribed and managed by the patient's headache provider.
- Experimental: CBT aloneThis intervention arm consists of 6 Cognitive Behavioral Therapy (CBT), a mind and body based intervention using education on gate control theory of pain, behavioral strategies such as muscle relaxation, activity pacing, and cognitive strategies including distraction, problem solving, and using calming self-statements.
Primary Outcome Measure
Change in number of headache days [ Time Frame: baseline to weeks 4-8 to weeks 20-24 (post treatment) ]
Central Contacts
- LeighAnn Chamberlin, MEd513-636-9739
- Megan Pfeiffer513-636-1846
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham Children's of Alabama | Birmingham | Alabama | 35233 | Scott Turner, DNP (PRINCIPAL_INVESTIGATOR) |
| Phoenix Children's Hospital - Barrow Neurological Institute | Phoenix | Arizona | 85016-7710 | Nigel Negm Reena Rastogi, Md (PRINCIPAL_INVESTIGATOR) |
| University of California San Francisco | San Francisco | California | 94115 | Ryan Moon Hannah Shapiro, MD (PRINCIPAL_INVESTIGATOR) |
| University of Colorado/Children's Hospital Colorado | Aurora | Colorado | 80045 | Theo Greiner Marcy Yonker, MD (PRINCIPAL_INVESTIGATOR) |
| Nemours Children's Health System | Wilmington | Delaware | 19810 | Judy Adelizzi-Delany, DNP (PRINCIPAL_INVESTIGATOR) |
| Clinical Integrative Research Center of Atlanta, Inc | Atlanta | Georgia | 30328 | Frank Berenson, MD (PRINCIPAL_INVESTIGATOR) Chaouki Khoury, MD (PRINCIPAL_INVESTIGATOR) |
| University of Louisville Health/Norton | Louisville | Kentucky | 40292 | Lauren Evansczyk Elizabeth Doll, MD (PRINCIPAL_INVESTIGATOR) |
| Louisiana State Univ/Children's Hospital of New Orleans | New Orleans | Louisiana | 70118-5720 | Kathryn Peneguy Rashmi Rao, MD (PRINCIPAL_INVESTIGATOR) |
| Dent Neurological Institute | Amherst | New York | 14226 | Jennifer McVige, MD (PRINCIPAL_INVESTIGATOR) |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Joanne Kacperski, MD (PRINCIPAL_INVESTIGATOR) |
| Nationwide Childrens | Columbus | Ohio | 43205 | Colin Peachey Ann Pakalnis, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Christina Szperka, MD (PRINCIPAL_INVESTIGATOR) |
| University of Tennessee Health Science Center/ LeBonheur Children's Hospital | Memphis | Tennessee | 38103 | Talia Hill Ankita Gosh, MD (PRINCIPAL_INVESTIGATOR) |
| Dell Children's Hospital-UT Health | Austin | Texas | 78712 | Sara Pavitt, MD (PRINCIPAL_INVESTIGATOR) |
| Marshall Health | Huntington | West Virginia | 25701 | Ivan Lopez, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
University of Alabama at Birmingham Children's of Alabama· Birmingham, ALPhoenix Children's Hospital - Barrow Neurological Institute· Phoenix, AZUniversity of California San Francisco· San Francisco, CAUniversity of Colorado/Children's Hospital Colorado· Aurora, CONemours Children's Health System· Wilmington, DEClinical Integrative Research Center of Atlanta, Inc· Atlanta, GA
Related Studies
- Analysis of Headache Chronification With Imaging, Deep Phenotyping, and ProteomicsRecruiting · Stanford University · Stanford, California
- Pain Biomarker StudyPHASE1 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive HeadachesRecruiting · Northwell Health · Manhasset, New York
- Mind Body Balance for Pediatric MigraineRecruiting · Children's Hospital Medical Center, Cincinnati · Aurora, Colorado